Everything you need to know about thyroid cancer, from early warning signs to treatment options. Doctors reveal crucial ...

In honor of Thyroid Awareness Month, we are exploring the causes of thyroid diseases and thyroid cancer in our community.

A 5-year follow-up of those randomized to receive or not receive radioiodine after thyroidectomy showed nearly the same low ...

Hurthle cell thyroid cancer (also called Hurtle cell carcinoma) is a rare sub-type of follicular thyroid cancer. Approximately 3% of thyroid cancer cases are Hurthle cell. Hurthle thyroid cells can be ...

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

For follicular cell-derived thyroid carcinoma (excluding anaplastic cancer), which accounts for approximately 97% of thyroid cancer cases, [40] serum thyroglobulin (Tg) represents a tumor marker ...

Papillary, follicular, and medullary thyroid cancers all have a 99.5% five-year relative survival rate for localized cancers ...

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer.

January is Thyroid Awareness Month. Learn how to spot the signs of thyroid issues and take proactive steps toward better ...

Researchers conducted a randomized controlled trial to assess the need for postoperative radioiodine therapy among patients with low-risk thyroid cancer.